ArticleFrontiers in neurology2025
Post-encephalitic epilepsy in patients with acute encephalopathy with biphasic seizures and late reduced diffusion.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Adjunctive remote ischaemic postconditioning and hypothermia therapy in acute encephalopathy with biphasic seizures.Pediatric research · 2026Article
- Alternating Hemispheric Diffusion-Weighted Imaging Abnormalities: A Characteristic Imaging Pattern in RHOBTB2 Encephalopathy.Korean journal of radiology · 2026Article
- Infant traumatic brain injury with a biphasic clinical course and late diffusion restriction: a case report.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a prevalent form of acute infection-triggered encephalopathy in children, excluding the unclassified type. It is marked by febrile seizures, referred to as early seizures and subsequent late seizures, along with a reduction in the apparent diffusion coefficient in cortical or subcortical white matter. AESD frequently results in neurological sequelae, including post-encephalitic epilepsy (PEE). Methods: This retrospective study examined the incidence of PEE and investigated whether therapeutic hypothermia reduced the risk of PEE in 45 patients with AESD treated at St Mary's Hospital between July 2008 and April 2024. Patients whose Glasgow Coma Scale score was >8 and who had mild clinical symptoms, as judged by the attending physician, between July 2008 and December 2020, did not undergo therapeutic hypothermia. However, all patients with AESD underwent therapeutic hypothermia during the period between January 2021 and April 2024. There were 11, 24, and 10 patients in the Early-Hypo, Late-Hypo, and Non-Hypo groups, respectively. Results: The prevalence of PEE among patients with AESD was 26.7% (12 out of 45 patients), with a median observation period of 75 months (IQR 37-98 months, range 20-182 months). Univariate analysis revealed statistically significant differences between patients with and without PEE in several factors, including Glasgow Coma Scale scores between 12 and 24 h after early seizures, and the number of patients with AESD with biphasic course, Tada scores, and the Pediatric Cerebral Performance Category at 6 months post-onset. Multivariate logistic regression analysis identified higher Tada scores as an independent risk factor for developing PEE, and the treatment options of Early-Hypo or Late-Hypo significantly reduced the risk of PEE. Conclusion: While further prospective studies with larger cohorts are warranted, this study highlights the association between higher Tada scores and an increased risk of PEE in patients with AESD, and the treatment options of Early-Hypo or Late-Hypo significantly reduced the risk of PEE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.